Skip directly to content

Registration and application

Depending upon the country in which you and your institution are based, you will be directed to register with and submit your application to either the BMS or the Pfizer website. This is due to the division of responsibilities between the two companies for handling investigator-initiated research.

  • First you will be required to register via the BMS or Pfizer investigator research submission portal.
  • Investigators submitting through the Pfizer IIR portal can use this Concept Summary Form or via contact with your local medical representative.
  • You do not need to submit the full protocol. The full protocol is required only if your proposal is selected to receive funding.
  • During the submission process the principal investigator will be requested to comply with BMS or Pfizer rules and regulations regarding investigator-sponsored research.

 

 
Global BMS ISR portal

 

Applicants from the following countries will be directed to the BMS website which can be accessed via the BMS portal after registration is completed.

AustriaUnited Kingdom
AustraliaBelgium
DenmarkFinland
FranceGermany
IcelandIreland
ItalyLiechtenstein
LuxembourgMalta
NetherlandsNorway
PortugalSouth Korea
SwedenSpain
 Switzerland
Global BMS ISR portal

 

Applicants from the following countries will be directed to the BMS website which can be accessed via the BMS portal after registration is completed.

AustriaUnited Kingdom
AustraliaBelgium
DenmarkFinland
FranceGermany
IcelandIreland
ItalyLiechtenstein
LuxembourgMalta
NetherlandsNorway
PortugalSouth Korea
SwedenSpain
 Switzerland
 

Pfizer IIR portal

 

Applicants from the following countries will be directed to the Pfizer Investigator Initiated Research (INSPIIRE) portal. Create an account and submit your proposed designated Concept Summary Form, which can be accessed after creating your account. Investigators from RUSSIA: Due to updated privacy law, Russian Investigators must first submit their application to a Pfizer local country office colleague before submitting on the portal. If you do not have a local country contact, please email IIR@Pfizer.com.

AlbaniaIsraelRomania
Bosnia HerzegovinaKazakhstanRussia
BulgariaKosovoSerbia
CroatiaLatviaSlovakia
Czech RepublicLithuaniaSlovenia
EstoniaMacedoniaTurkey
GeorgiaMontenegroUkraine
GreecePoland
HungaryRepublic of Cyprus

Pfizer IIR portal

 

Applicants from the following countries will be directed to the Pfizer Investigator Initiated Research (INSPIIRE) portal. Create an account and submit your proposed designated Concept Summary Form, which can be accessed after creating your account.

AlbaniaBosnia Herzegovina
BulgariaCroatia
Czech RepublicEstonia
GeorgiaGreece
HungaryIsrael
KazakhstanKosovo
LatviaLithuania
MacedoniaMontenegro
PolandRepublic of Cyprus
RomaniaRussia
SerbiaSlovakia
SloveniaTurkey
Ukraine

 

Additional support

 

To request further information on the program in your country please contact your local BMS/Pfizer medical and scientific support colleague.

 

For technical support for the BMS website, please e-mail isr.help@bms.com or call the ISR Hotline in the US: +1-888-930-5700. For technical support for the Pfizer IIR website, please email IIR@Pfizer.com

This site is intended for the use of investigators considering a submission or intending to submit to the ERISTA program. It is NOT intended to provide product information.